Related Experiment Video
Updated: Jun 2, 2026
09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Sequencing: the next generation. Moving beyond population-based recessive disease carrier screening
1San Francisco Genetics Department, The Kaiser Permanente Medical Group, 2350 Geary Blvd, San Francisco, CA 94115, USA. Christine.x.kobelka@kp.org
Clinical Genetics
|April 12, 2011
Summary
Next-generation sequencing enables comprehensive carrier testing for severe childhood recessive diseases. This advancement significantly improves genetic screening for inherited conditions.
Area of Science:
- Medical Genetics
- Genomic Medicine
- Pediatric Diseases
Background:
- Recessive genetic disorders in children pose significant health challenges.
- Accurate carrier identification is crucial for reproductive planning and disease prevention.
- Traditional carrier screening methods may be limited in scope and efficiency.
Discussion:
- Next-generation sequencing (NGS) offers a powerful tool for broad carrier screening.
- NGS allows for simultaneous testing of multiple genes associated with severe childhood diseases.
- This approach enhances the diagnostic yield and cost-effectiveness of genetic screening.
Key Insights:
- NGS-based carrier testing can identify carriers of severe childhood recessive diseases with high accuracy.
- The study demonstrates the clinical utility of NGS for expanding genetic screening programs.
- Implementing NGS for carrier testing can lead to earlier identification and management of at-risk families.
Outlook:
- Future applications of NGS in carrier screening for a wider range of genetic conditions.
- Potential for integrating NGS carrier testing into routine prenatal and preconception care.
- Advancements in sequencing technology may further reduce costs and increase accessibility.
Related Concept Videos
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
02:51Multi-species Conserved Sequences
Next-generation sequencing technologies have created large genomic databases of a variety of animals and plants. Ever since the human genome project was completed, scientists studied the genome of primates, mammals, and other phylogenetically distant living beings. Such large-scale studies have provided new insights into the evolutionary relationship between organisms.
Although the genome of each species varies greatly from each other, a few sequences are highly conserved. Such conserved DNA...
Although the genome of each species varies greatly from each other, a few sequences are highly conserved. Such conserved DNA...